Status:
NOT_YET_RECRUITING
Intraarticular Gold Microparticles for Hip Osteoarthritis
Lead Sponsor:
Northern Orthopaedic Division, Denmark
Collaborating Sponsors:
Aalborg University Hospital
Conditions:
Osteoarthritis, Hip
Eligibility:
All Genders
18+ years
Brief Summary
In a pilot study, the investigators recently showed that intraarticular metallic gold microparticles reduce knee osteoarthritis pain for up to two years and found associated significant proteomic chan...
Detailed Description
A cohort of 20 patients, aged ≥ 18 years, with pain ≥ 3 months, and Kellgren-Lawrence OA grade 2-4, will beincluded. Metallic gold 20 mg, 72.000 pieces, 20-40 µ-meter (Berlock-Micro-Implants, HumanGol...
Eligibility Criteria
Inclusion
- confirmed moderate hip OA (Kellgren-Lawrence grade ≥ 2), pain for more than 3 months, and maximal pain intensity VAS (Visual Analogue Scale, 0-10) ≥ 5 during the last week
Exclusion
- exclusion criteria were 1) malignancy, 2) active infection and antibiotic treatment, 3) active treatment with steroids, biological or other anti-rheumatic medication, 4) history of chronic pain condition, 5) inability to comply with the protocol, and 6) inadequacy in written and spoken national language.
Key Trial Info
Start Date :
March 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06186115
Start Date
March 4 2024
End Date
May 1 2024
Last Update
January 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital
Aalborg, Region Northern Jutland, Denmark, 9000